Professional Documents
Culture Documents
Physiology in Medicine
Dennis A. Ausiello, MD, Editor; Dale J. Benos, PhD, Deputy Editor; Francois Abboud, MD, Associate Editor;
Review
William Koopman, MD, Associate Editor
Annals of Internal Medicine
Paul Epstein, MD, Series Editor
Three major high-altitude diseases Hypoxia of high altitude impairs physical performance,
mental performance, and sleep.
Acute mountain sickness (headache, lightheadedness,
fatigue, insomnia, anorexia) In acclimatization, hyperventilation is the most important
feature. Acclimatization reduces but does not abolish the
High-altitude pulmonary edema (dyspnea, reduced exercise effects of hypoxia.
tolerance, cough, tachycardia, crepitations)
Extreme altitude causes severe hypoxemia, respiratory
High-altitude cerebral edema (confusion, ataxia, mood alkalosis, and greatly reduced maximal oxygen
changes, coma, papilledema) consumption.
Figure 1. Relationship among altitude, barometric pressure, and hypoxia-inducible factor-1 complex, which regulates gene
inspired PO2. transcription. This complex is a heterodimer protein com-
plex that activates transcription through binding to specific
hypoxic-responsive sequences present in various genes en-
coding for glycolytic enzymes, growth factors, and vasoac-
tive peptide (7).
The physiologic effects of the hypoxia of high altitude
on the human body are legion. The most important in the
present context can be considered under 3 headings: phys-
ical performance, mental performance, and sleep.
than they usually need to during the workday. However, Figure 2. Alveolar PO2 at high altitude for persons acutely
most people working at an altitude of 4000 m experience exposed and persons fully acclimatized.
an increased number of arithmetic errors, reduced atten-
tion span, and increased mental fatigue. Visual sensitivity
(for example, night vision) is reduced at altitudes as low as
2000 m and has been shown to decrease by about 50% at
an altitude of 5000 m, where there are also measurable
differences in attention span, short-term memory, arith-
metic ability, and decision making (12).
The molecular and cellular mechanisms responsible
for impaired mental performance during hypoxia are
poorly understood. The brain normally accounts for ap-
proximately 20% of the body’s total oxygen consumption,
and the oxygen is almost entirely used for the oxidation of
glucose. Suggested mechanisms for the impairment of
nerve cell function during hypoxia include altered ion ho-
meostasis, changes in calcium metabolism, alterations in
neurotransmitter metabolism, and impairment of synapse
function (13–15).
Sleep
Sleep is also impaired at high altitude, and many peo- The altitudes of several observatories where astronomers work are shown.
Note that fully acclimatized astronomers on the summit of Mauna Kea
ple find this one of the most distressing features of staying have an alveolar PO2, and therefore an arterial PO2, lower than the
there. People at high altitude often wake frequently, have threshold for continuous oxygen therapy in patients with chronic ob-
unpleasant dreams, and do not feel refreshed in the morn- structive pulmonary disease (COPD). The dashed-and-dotted lines indi-
cate the normal value at sea level (upper line) and the threshold for
ing (16). The periodic breathing that occurs in most peo- continuous O2 therapy in COPD (lower line).
ple at altitudes above 4000 m is probably an important
causative factor (17). Periodic breathing is thought to re-
sult from instability in the control system through the hy- V̇CO2
PCO2 ⫽ 䡠K
poxic drive (18) or the response to carbon dioxide (19). V̇A
The low levels of oxygen in the blood after apneic periods
may be responsible for some of the arousals. Experienced where V̇A is the alveolar ventilation and V̇CO2 is the CO2
trekkers and mountain climbers often recommend climb- production. At the same time, the increased alveolar ven-
ing high but sleeping low to mitigate these problems. tilation increases the alveolar PO2. In other words, the pro-
cess of hyperventilation tends to defend the alveolar PO2
against the decrease in inspired PO2 (Figure 2).
The extent of hyperventilation at high altitude can be
ACCLIMATIZATION TO HIGH ALTITUDE
enormous. To take an extreme example, on the summit of
The adaptive changes collectively known as acclimati- Mount Everest, where the inspired PO2 is only 29% of its
zation greatly improve the tolerance of human beings to sea level value (Table 1), the alveolar ventilation is in-
high altitude. Physiologists often cite high-altitude accli- creased approximately 5-fold. As a result, the alveolar PCO2
matization as one of the best examples of how the body is reduced to 7 to 8 mm Hg, about one fifth of its normal
responds to a hostile environment. However, although ac- sea level value of 40 mm Hg (20). The alveolar PO2 is then
climatization is critically important, several misconceptions maintained near 35 mm Hg, which is certainly very low
have developed. but just sufficient to keep the climber alive.
Hyperventilation Polycythemia
By far the most important feature of acclimatization is Many physicians who are asked to name the most im-
the increase in depth and rate of breathing, which results in portant feature of acclimatization will probably answer
an increase in alveolar ventilation. This is brought about by polycythemia. It is true that both lowlanders (people who
hypoxic stimulation of the peripheral chemoreceptors, normally live at or near sea level) who remain at high
mainly the carotid bodies, which sense the low PO2 in the altitude for a long period and highlanders (people born and
arterial blood. Hyperventilation reduces the alveolar PCO2 bred at high altitude) have increased erythrocyte concen-
because there is an inverse relationship between this and trations and therefore high blood oxygen capacities. How-
the alveolar ventilation for a fixed rate of carbon dioxide ever, polycythemia develops relatively slowly. It takes sev-
production: eral days before an increased rate of erythrocyte production
www.annals.org 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 791
can be measured, and the process is not complete for sev- Array) (5050 m). Sites near Chajnantor up to an altitude of
eral weeks (21). Therefore, in the context of acclimatiza- 5800 m have occasionally been used for scientific measure-
tion to high altitude over the course of a week or so (the ments.
usual length of many visits to high altitude), polycythemia Among astronomers working at Mauna Kea, acute ex-
does not play an important role. posure to the altitude of the summit after ascent from near
Newcomers to high altitude often develop a transient sea level results in an alveolar PO2 of approximately 45 mm
increase in erythrocyte concentration, but this is caused by Hg. With full acclimatization, the PO2 increases to about
a reduced plasma volume, not an increased rate of eryth- 54 mm Hg on average. However, full acclimatization takes
rocyte production (22). Dehydration may be a factor in the several days and never occurs for astronomers on Mauna
reduced plasma volume; it is very common at high altitude, Kea because of the limited accommodation and work
partly because of the great insensible fluid loss mainly schedules.
caused by the large ventilation of cold dry air (23). Hor- The severity of arterial hypoxemia is emphasized by
monal changes regulating plasma volume also occur (24), comparing these astronomers with patients who have
and thirst is inappropriately reduced. A reduced fluid in- chronic obstructive pulmonary disease (COPD). Even if
take is often a factor, and diuresis may occur. the alveolar PO2 of the astronomers reached a value of 54
mm Hg, the arterial PO2 would be 2 or 3 mm Hg lower,
Acid–Base Changes
assuming normal lungs. Figure 2 also shows the arterial
The acute reduction in alveolar and therefore arterial
PO2 threshold of 55 mm Hg, below which patients with
PCO2, which was mentioned earlier, causes respiratory al-
COPD are entitled to continuous oxygen therapy under
kalosis with an increased pH in both the cerebrospinal
Medicare (27). In other words, if the arterial hypoxemia of
fluid and arterial blood. However, after a day or so, the pH
an astronomer on Mauna Kea was caused by COPD, this
of the cerebrospinal fluid changes toward normal by move-
person would be entitled to continuous oxygen therapy.
ment of bicarbonate out of the cerebrospinal fluid, and
Of course, there are differences between healthy per-
after 2 or 3 days the pH of the arterial blood moves toward
sons at high altitude and patients with COPD. For exam-
normal by renal excretion of bicarbonate. The rate and
ple, the pulmonary hypertension of COPD, which is partly
extent of the metabolic compensation depend on the alti-
relieved by continuous oxygen therapy (27), is not solely
tude being slower and less complete at very high altitudes.
due to alveolar hypoxia, which is the primary factor at high
The initial alkalosis in both the cerebrospinal fluid and the
altitude. However, it is important to note that 6 months of
blood tends to inhibit hyperventilation through the action
continuous oxygen therapy through nasal prongs in pa-
of both the central chemoreceptors in the brainstem and
tients with COPD, which is sufficient to raise the resting
the peripheral chemoreceptors in the carotid and aortic
arterial PO2 to between 60 and 80 mm Hg, results in a
bodies. The sensitivity of the carotid body to hypoxia also
statistically significant improvement in neuropsychological
increases during prolonged exposure to high altitude (25).
function (measured during air breathing) (28). In addition,
Misconceptions about Acclimatization 61% of patients with COPD who have an average arterial
Almost everybody who ascends to altitudes of 2500 to PO2 of 54 mm Hg or less show neuropsychological deficits
3000 m or above is aware of the advantages of acclimati- compared with age- and education-matched controls (29).
zation. However, an important misconception about accli- These findings should give pause to astronomers who elect
matization has developed, particularly among people who to alleviate hypoxemia by acclimatization rather than by
are not in the medical field. I have become very aware of oxygen enrichment of room air, which is discussed later in
this in talking to astronomers who work in observatories this article.
on the summit of Mauna Kea, Hawaii, where the altitude
is 4200 m. Many of these people have come to believe that
the process of acclimatization returns the body to its sea IMPROVING WORKING EFFICIENCY AT HIGH ALTITUDE
level condition or, in other words, that the hypoxia of high Populations at Risk
altitude is nullified by the process of acclimatization. Until recently, interest in high-altitude medicine and
The true situation is indicated in Figure 2, which physiology was mainly directed to 2 groups. One is the
shows typical alveolar PO2 values for people after acute large number of lowlanders who journey to high altitude
exposure to high altitude and after full acclimatization. for recreational purposes, including skiing, trekking, and
These data are based on the study of Rahn and Otis (26), mountaineering. Many of these people develop high-alti-
although there is considerable individual variation. Figure tude diseases, although fortunately the most common
2 shows several reference altitudes, including that of the problem by far is the relatively innocuous acute mountain
laboratories of the University of California White Moun- sickness. The other extensively studied group involves peo-
tain Research Station (3800 m); the summit of Mauna ple who reside permanently at high altitude.
Kea, where several telescopes are located (4200 m); and In the past few years, another group has been increas-
Chajnantor, Chile, the site of construction of the enor- ingly studied: those who are required to work at high alti-
mous radiotelescope ALMA (Atacama Large Millimeter tude. Usually, such people are commuters in the sense that
792 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 www.annals.org
they normally live near sea level but work at high altitude. Figure 3. Alveolar PO2 and PCO2 of acclimatized humans at high
Until very recently, miners were the largest group in this altitude.
category, particularly in the South American Andes. As an
example, several thousand miners work in the Collahuasi
mine in north Chile at altitudes of approximately 4500 m,
although their sleeping accommodation is somewhat lower
(3800 m). Their working schedule is remarkable in that
they and their families live on the coast at sea level. At the
beginning of their working week, they are bused up to the
mine, where they typically spend the next 7 days working
long shifts of 12 hours per day. They are then bused down
to their homes, where they spend the next 7 days. The
result is that these workers acclimatize to an altitude be-
tween 4500 m and sea level. A prospective study of the
medical and physiologic characteristics of this group has
been under way for the past 3 years (3).
Table 2. Alveolar Gas and Estimated Arterial Blood Values on the Summit of Mount Everest
In 1981, the American Medical Research Expedition can be studied by prolonged exposure of volunteers in a
to Everest was planned to obtain physiologic measure- low-pressure chamber. For example, in Operation Everest
ments at extreme altitudes, including the summit. Alveolar II, 8 healthy persons spent approximately 40 days and
gas samples were collected on the summit, barometric pres- nights in a chamber in which the pressure was gradually
sure was measured there for the first time, and many other reduced (33). However, for reasons that are not clear, full
measurements were made above an altitude of 8000 m and acclimatization does not occur under these conditions.
at somewhat lower altitudes in 2 laboratories (32). Figure 3 Nevertheless, the “summit” measurements of arterial PO2
shows the alveolar PO2 and PCO2 as humans ascended from and maximal oxygen consumption agreed well with those
sea level to the summit of Mount Everest. The PO2 de- obtained in the field.
creased because of the reduction in inspired PO2, while the Very few additional data at extreme altitudes have
PCO2 decreased because of the increasing hyperventilation. been obtained in the past 20 years. However, some mea-
Note that at the summit, the alveolar PCO2 was reduced to surements of alveolar PO2 by fuel cell and arterial oxygen
the extraordinarily low level of 7 to 8 mm Hg. This implies saturation by pulse oximetry were taken during an ascent
an increase in alveolar ventilation of about 5 times the sea to 8000 m on Mount Everest (34). The results agreed with
level value. Of interest, above an altitude of about 7000 m, those found on American Medical Research Expedition to
alveolar PO2 did not decrease further. Rather, it was de- Everest but did not correspond as well with those obtained
fended at a level of about 35 mm Hg by increasing hyper- in the chamber study, again suggesting incomplete accli-
ventilation. In other words, the extreme hyperventilation matization in the latter.
insulated the PO2 in the alveolar gas from the decreasing
PO2 in the inspired air. Hyperventilation is by far the most
HIGH-ALTITUDE DISEASES
important physiologic adaptation at these extreme alti-
tudes. There are 3 major high-altitude diseases—acute
It was not feasible to sample arterial blood on the mountain sickness, high-altitude pulmonary edema, and
summit, but the arterial PO2 could be estimated from the high-altitude cerebral edema—as well as many other less
Bohr integration along the pulmonary capillary. In addi- important conditions.
tion, the arterial pH was derived from the measured Acute Mountain Sickness
alveolar PCO2 and the measured base excess in samples Acute mountain sickness is very common in people
of venous blood. The results are shown in Table 2. The who ascend from near sea level to altitudes higher than
barometric pressure was 253 mm Hg, almost exactly one approximately 3000 m, but it may occur at altitudes as low
third of the sea level value. This means that the inspired as 2000 m. It is characterized by headache, lightheaded-
PO2 on the summit was 43 mm Hg. The alveolar PO2 was ness, breathlessness, fatigue, insomnia, anorexia, and nau-
kept at the just-viable value of 35 mm Hg by extreme sea (35, 36). Typically, symptoms begin 2 or 3 hours after
hyperventilation, but the arterial PO2 was lower because of ascent, but the condition is generally self-limiting and most
diffusion limitation across the blood– gas barrier under of the symptoms disappear after 2 or 3 days. However,
these extraordinary conditions. The PCO2 was 7 to 8 mm insomnia may persist. Descent to low altitude rapidly re-
Hg, and the pH exceeded 7.7 (20). An interesting result of verses acute mountain sickness.
this extreme alkalosis is that it increases the oxygen affinity The precise pathogenesis of acute mountain sickness is
of hemoglobin, which facilitates loading of oxygen by the not understood. Of course, hypoxia is likely to be a major
pulmonary capillaries. It is astonishing that humans can factor, although respiratory alkalosis may also play a role.
tolerate and survive such extraordinary insult to their nor- The latter would fit with the time course of resolution.
mal physiologic makeup. Maximal oxygen uptake was Mild cerebral edema may occur secondary to increased ce-
measured on well-acclimatized persons breathing an in- rebral blood flow and perhaps altered permeability of the
spired PO2 of 43 mm Hg (the same as on the summit), blood– brain barrier. There is some evidence of slight brain
yielding a value of just over 1 L/min. This is equivalent to swelling and increased intracranial pressure. A low arterial
the oxygen uptake when someone walks slowly on level PO2 results in cerebral vasodilatation (37), while a low
ground but is just sufficient to explain how a climber can PCO2 causes vasoconstriction (38).
reach the summit. The best way to prevent acute mountain sickness is by
Some of the physiologic changes of extreme altitude ascending gradually and allowing time for acclimatization.
794 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 www.annals.org
A popular rule of thumb among trekkers is that above an Figure 4. Ultrastructural changes in the wall of a pulmonary
altitude of 3000 m, each day’s ascent should not average capillary when the capillary hydrostatic pressure is raised.
more than 300 m, with a rest day every 2 or 3 days. This is
a conservative ascent rate, and many people are able to
increase this to 400 m to 600 m per day. Even a brief
recent exposure to high altitude affords some protection
against acute mountain sickness (39).
The carbonic anhydrase inhibitor acetazolamide is use-
ful for prophylaxis if rapid ascent is inevitable, as in, for
example, a flight to La Paz, Bolivia. Acetazolamide pro-
duces metabolic acidosis by increasing the renal excretion
of bicarbonate, which in turn stimulates ventilation. The
dosage is 250 mg once or twice daily, and 125 mg taken at
night will sometimes improve sleep. A recent meta-analysis
concluded that daily prophylactic doses of less than 750
mg were ineffective (40); however, this runs contrary to
much clinical experience and probably reflects the exclu-
sion of some studies. Side effects of acetazolamide are com-
mon and include diuresis, paresthesia of fingers and toes, The arrows at the top show a disruption in the alveolar epithelial layer;
the arrows at the bottom show a break in the capillary endothelial layer,
and a flat unpleasant taste to carbonated drinks. Acetazol- with a platelet apparently adhering to the exposed basement membrane.
amide is a sulphonamide drug, and therefore some people These changes are caused by the high mechanical stress in the capillary
have a hypersensitivity to it. Dexamethasone is also effec- wall. Modified from reference 56. ALV ⫽ alveolus; CAP ⫽ capillary
lumen.
tive in preventing acute mountain sickness, although its
mode of action is unknown. The recommended prophy-
lactic dosage for adults is 2 mg every 6 to 8 hours. In stained sputum. Tachypnea and tachycardia are common
addition, Gingko biloba has been suggested as a useful pro- on examination. In addition, there is often mild pyrexia,
phylactic agent but has not been sufficiently studied. and crepitations (crackles) can be detected by auscultation.
Treatment of acute mountain sickness by oxygen or The pathogenesis of high-altitude pulmonary edema is
descent is usually not required, although aspirin, acetami- still a subject of study, but strong evidence indicates that it
nophen, or ibuprofen may relieve headache. Acetazolamide, is triggered by pulmonary hypertension as a result of hy-
250 mg 3 times per day, is helpful in relieving symptoms, poxic pulmonary vasoconstriction. It is likely that the hy-
as is dexamethasone, 4 mg 4 times per day, if the condition poxic pulmonary vasoconstriction is patchy, with the result
is severe. Severe prolonged acute mountain sickness re- that some pulmonary capillaries are exposed to the high
sponds well to descent. pressure. This causes damage to the capillary walls (stress
failure), and they leak a high-protein edema fluid with
High-Altitude Pulmonary Edema erythrocytes. Studies of alveolar fluid obtained by bron-
High-altitude pulmonary edema is a potentially fatal choalveolar lavage in high-altitude pulmonary edema have
condition that typically occurs 2 to 4 days after ascent to convincingly shown that this is a high-permeability type of
altitudes above 3000 m (41). With usual ascent rates, the edema (44). However, cardiac catheterization studies have
incidence is about 1% to 2%, but as many as 10% of demonstrated normal pulmonary wedge pressures (45), so
people ascending rapidly to 4500 m may develop the con- this is not a form of left-heart failure.
dition (42). High-altitude pulmonary edema is also seen in The evidence for the importance of pulmonary hyper-
residents of high altitudes who travel to a lower altitude tension can be summarized as follows. Cardiac catheriza-
and then return; this is termed reascent high-altitude pul- tion studies in patients with high-altitude pulmonary
monary edema. There is considerable individual variability, edema have shown pulmonary artery systolic pressures as
and people who develop high-altitude pulmonary edema high as 144 mm Hg, with a usual range of 60 to 80 mm
once are more likely to do so again. Some evidence indi- Hg (46, 47). Susceptible individuals tend to have an un-
cates that an upper respiratory tract infection may increase usually strong hypoxic pulmonary vasoconstriction re-
susceptibility, and people with restricted pulmonary circu- sponse (48) and unusually high pulmonary artery pressures
lation, such as unilateral absence of a pulmonary artery, are before the onset of high-altitude pulmonary edema (49).
particularly at risk (43). Pulmonary vasodilator drugs are useful in the prevention
High-altitude pulmonary edema may be preceded by and treatment of this disorder (49, 50). As indicated ear-
acute mountain sickness, but this is not always the case. lier, a restricted pulmonary vascular bed (for example, uni-
The predominant symptom is dyspnea with reduced exer- lateral absence of a pulmonary artery) is a recognized risk
cise tolerance. There is often a dry cough at first, but this factor (43). Exercise that increases pulmonary artery pres-
may progress to a cough that produces frothy, blood- sure may also play a role (51). Convincing evidence that
www.annals.org 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 795
See text for details. Modified from reference 62. PA ⫽ pulmonary artery.
the alveolar edema is of the high-permeability type with pulmonary edema and explain the high-permeability form
large concentrations of high-molecular-weight proteins and of edema with the leak of high-molecular-weight proteins
cells comes from bronchoalveolar lavage studies (44, 52). and cells. Of interest, sometimes blood platelets are seen
Later in the disease, the edema fluid contains markers of an adhering to the exposed basement membrane. This could
inflammatory response (53), although this is not seen in explain activation of these cells by this highly reactive, elec-
the very early stages (54). Changes in blood coagulation trically charged surface and could also explain the markers
and platelet activation also occur later in the disease (55). of an inflammatory response that develop later in the disease.
On the basis of these findings, a likely pathogenic One of the interesting features of the ultrastructural
mechanism for high-altitude pulmonary edema is that the changes in the pulmonary capillaries is that they are readily
high pulmonary artery pressure is transmitted to some of reversible. For example, if the pressure in the pulmonary
the capillaries and the resulting high wall stresses cause capillaries is first increased and then lowered to normal
ultrastructural changes. Capillaries in areas of the lung levels for a few minutes, approximately 70% of the disrup-
where vasoconstriction is not effective (for example, be- tions in both the capillary endothelium and the alveolar
cause of the paucity of vascular smooth muscle) may be epithelium disappear (58). This rapid resolution of the
exposed to a pressure close to that in the pulmonary artery. pathologic changes fits well with the remarkably rapid im-
The process has been studied in animal preparations, provement in patients’ clinical status when they are moved
where the pulmonary capillary pressure was increased by to a lower altitude. We do not fully understand the micro-
cannulating the pulmonary artery and left atrium and the mechanics of the processes responsible for the ultrastruc-
lung parenchyma was fixed for electron microscopy by in- tural changes, but it has been suggested that distortion of
travascular perfusion of buffered glutaraldehyde (56, 57). the type IV collagen matrix in the basement membranes
The results show disruption of the capillary endothelial may be a factor (59). There is evidence that the basement
layer, alveolar epithelial layer, and, in some cases, all layers membrane is responsible for the strength of the blood– gas
of the wall (Figure 4). These changes are seen with trans- barrier, at least on the thin side (60).
mural pressures considerably lower than the pulmonary ar- Additional evidence that these ultrastructural changes
terial pressures that have been measured in high-altitude are caused by high wall stresses resulting from the high
796 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 www.annals.org
pulmonary capillary pressures comes from an analysis of closely related and that high-altitude cerebral edema is the
the wall stresses in the extremely thin blood– gas barrier extreme end of the spectrum. The incidence is difficult to
that forms the wall of the capillary. This analysis shows estimate but may be as high as 1% to 2% in people as-
that these stresses approach the breaking stress of type IV cending above 4500 m.
collagen (59). The basic reason for these extremely high Classically, the patient becomes confused and ataxic
wall stresses is that the blood– gas barrier on the thin side is and may experience mood changes. Hallucination has been
so extraordinarily thin. The blood– gas barrier needs to be described, and serious cases involve coma followed by
extremely thin for effective gas exchange by diffusion but death. On examination, patients may have papilledema
also strong enough to withstand these large stresses (61). and occasionally focal neurologic signs affecting cranial
The pathogenic processes are summarized in Figure 5. nerves, or even hemiparesis. The pathogenesis is almost
Of interest, if high-altitude pulmonary edema does certainly cerebral edema, possibly related to an increased
not develop within 4 or 5 days of someone moving to high cerebral blood flow. A few autopsies have shown cerebral
altitude, it does not develop at all unless the altitude is edema with swollen flattened gyri (69 –71). Magnetic res-
increased again. This is probably because the alveolar hyp- onance imaging scans in a few patients have shown intense
oxia induces vascular remodeling along with the vaso- T2 signals in white matter, particularly in the splenium and
constriction. We know that remodeling of the pulmo- corpus callosum, consistent with edema (72).
nary arteries begins very rapidly when the wall tension is Again, the cardinal rule in treatment is descent to a
increased. For example, Tozzi and colleagues (63) showed lower altitude as quickly as possible. Oxygen should be
that the synthesis of collagen and elastin increased along administered if possible. Dexamethasone should be given;
with increased gene expression for several growth factors the suggested dose is 8 mg initially followed by 4 mg every
within 4 hours of applying stretch to pulmonary artery 6 hours. This drug is also useful to relieve the cerebral
segments in vitro. Therefore, it seems possible that the symptoms of severe acute mountain sickness (73). If
capillaries, which are at risk because the small pulmonary descent to a lower altitude is not feasible because of the
arteries upstream of them are nearly devoid of smooth remote situation, portable hyperbaric bags such as the
muscle, are protected when sufficient remodeling occurs. Gamow bag can be used for both high-altitude cerebral
Basically, the same explanation could account for the re- edema and high-altitude pulmonary edema. The patient is
ascent high-altitude pulmonary edema mentioned earlier, placed inside the bag and the pressure is increased with a
which occurs in residents of high altitude when they go to foot pump, thus reducing the effective altitude. Patients
a lower altitude, typically for a few days, and then return. with high-altitude cerebral edema sometimes recover very
Presumably, some vascular smooth muscle undergoes invo- rapidly after descent to a lower altitude.
lution during the time spent at low altitude. Other High-Altitude Diseases
The prevention and treatment of high-altitude pulmo- Chronic Mountain Sickness
nary edema are consistent with the pathogenic mechanism Permanent residents of high altitudes sometimes de-
described above. The disease is much more likely to occur velop a condition characterized by severe polycythemia and
after sudden ascent to high altitude. For example, as noted a constellation of neurologic symptoms, including head-
earlier, a rapid ascent to 4500 m results in an incidence of ache, somnolence, fatigue, and depression. The hematocrit
up to 10% (42), whereas the usual incidence with more can reach extremely high levels, and values above 0.8 have
gradual ascent is 1% to 2%. An additional risk factor is been recorded (74). The very high hematocrit increases the
strenuous exercise, particularly if coupled with a rapid as- viscosity of the blood, and in fact it is often difficult to
cent (64). In people who have previously developed high- draw venous blood as a result. Typically, the condition
altitude pulmonary edema, nifedipine (20 mg of a slow- improves considerably if the patient is moved to a lower
release preparation every 8 hours) reduces the incidence altitude but reappears after return to high altitudes. Ther-
(65). The cardinal principle for treating high-altitude pul- apeutic phlebotomy has been shown to reduce the symp-
monary edema is to remove the patient to a lower altitude toms. Respiratory stimulants (for example, medroxyproges-
as quickly as possible. Oxygen should be administered if terone acetate) have been used (75) because patients often
available. In addition, nifedipine has been shown to help experience some hypoventilation. Of interest, this disease is
relieve symptoms. The suggested regimen is 20 mg of the commonly seen in the Andes but is much rarer in Tibet.
slow-release preparation by mouth every 6 to 12 hours (36). Some anthropologists believe that true genetic adaptation
Other vasodilators, such as nitric oxide, may also be effective to high altitude has proceeded further in Tibetans than in
but are usually not feasible in the field. Recent work indicates Andeans because the former have resided at high altitudes
that salmeterol (66) and sildenafil (67) may also be useful. for much longer (76).
High-Altitude Cerebral Edema
High-altitude cerebral edema is rare but potentially Subacute Mountain Sickness
very serious (68). The condition often follows acute moun- This somewhat confusing term has been applied to 2
tain sickness, and many people think that the two are different conditions. One involves infants at high altitude
www.annals.org 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 797
who present with respiratory distress, marked cyanosis, and Requests for Single Reprints: John B. West, MD, PhD, Department of
congestive heart failure (77). The other affects young Medicine, University of California, San Diego, 0623A, 9500 Gilman
Drive, La Jolla, CA 92093-0623; e-mail, jwest@ucsd.edu.
adults in the Indian army who were posted to altitudes of
approximately 6000 m for many months and developed
dyspnea, cough, angina at effort, and dependent edema
References
(78). These conditions may be related to so-called brisket
1. Moore LG, Niermeyer S, Zamudio S. Human adaptation to high altitude:
disease in cattle (79), which is a form of right-heart failure regional and life-cycle perspectives. Am J Phys Anthropol. 1998;Suppl 27:25-64.
with peripheral edema. [PMID: 9881522]
2. West JB, Readhead A. Working at high altitude: medical problems, miscon-
ceptions, and solutions. Observatory. 2004;124:1-14.
Retinal Hemorrhage 3. Richalet JP, Donoso MV, Jiménez D, Antezana AM, Hudson C, Cortès G,
et al. Chilean miners commuting from sea level to 4500 m: a prospective study.
Retinal hemorrhage is very common in people who High Alt Med Biol. 2002;3:159-66. [PMID: 12162860]
ascend above 5000 m, although it usually causes no visual 4. Torricelli E. Letter of Torricelli to Michelangelo Ricci. 1644. In: West JB, ed.
impairment (80). The condition resolves on return to a High Altitude Physiology. Stroudsburg, PA: Hutchinson Ross; 1981:60-3.
lower altitude and may be related to increased retinal blood 5. Manual of the ICAO Standard Atmosphere. Montreal, Quebec: International
flow. Civil Aviation Organization; 1964.
6. West JB, Lahiri S, Maret KH, Peters RM Jr, Pizzo CJ. Barometric pressures
at extreme altitudes on Mt. Everest: physiological significance. J Appl Physiol.
1983;54:1188-94. [PMID: 6863078]
CONCLUSION 7. Semenza GL. Surviving ischemia: adaptive responses mediated by hypoxia-
In summary, the basic physiologic mechanism of high- inducible factor 1. J Clin Invest. 2000;106:809-12. [PMID: 11018065]
8. Cerretelli P. Gas exchange at high altitude. In: West JB, ed. Pulmonary Gas
altitude diseases is the low PO2 in the inspired gas, which
Exchange. v II. New York: Academic Pr; 1980:97-147.
results from the reduced barometric pressure. The most 9. Bigland-Ritchie B, Vollestad NK. Hypoxia and fatigue: how are they related?
important consequences of ascent to high altitude in In: Sutton JR, Houston CS, Coates G, eds. Hypoxia: The Tolerable Limits.
healthy persons can be classified under the 3 headings of Indianapolis, IN: Benchmark Pr; 1988:315-26; discussion 326-8.
reduced maximal oxygen consumption, impaired mental 10. Suarez J, Alexander JK, Houston CS. Enhanced left ventricular systolic
performance, and disordered sleep. The deleterious effects performance at high altitude during Operation Everest II. Am J Cardiol. 1987;
60:137-42. [PMID: 3604926]
of high altitude are greatly reduced by the process of accli-
11. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P,
matization, the most important feature of which is hyper- Dollery C, et al. Human gene for physical performance [Letter]. Nature. 1998;
ventilation caused by hypoxic stimulation of peripheral 393:221-2. [PMID: 9607758]
chemoreceptors. However, a prevailing misconception 12. McFarland RA. Psychophysiological implications of life at altitude and in-
about acclimatization is that it returns the body to near cluding the role of oxygen in the process of aging. In: Yousef MK, Horvath SM,
Bullard RW, eds. Physiological Adaptations: Desert and Mountain. New York:
normal, a serious error. Increasingly, people who normally Academic Pr; 1972:157-81.
live near sea level are being required to work at high alti- 13. Siesjo BK. Brain Energy Metabolism. New York: Wiley; 1978.
tudes, and an important recent advance, oxygen enrich- 14. Haddad GG, Jiang C. O2 deprivation in the central nervous system: on
ment of room air, increases productivity, reduces fatigue, mechanisms of neuronal response, differential sensitivity and injury. Prog Neu-
and improves sleep. Extraordinary physiologic adaptations robiol. 1993;40:277-318. [PMID: 7680137]
occur at extreme altitudes, such as the summit of Mount 15. Hossmann KA. The hypoxic brain. Insights from ischemia research. Adv Exp
Med Biol. 1999;474:155-69. [PMID: 10635000]
Everest, including an arterial PO2 of approximately 30 mm
16. Barcroft J, Cooke A, Hartridge H, Parsons TR, Parsons W. The flow of
Hg, PCO2 of less than 10 mm Hg, and pH over 7.7. Three oxygen through the pulmonary epithelium. J Physiol (Lond). 1920;53:450-72.
main high-altitude diseases are recognized: acute mountain 17. Weil JV. Sleep at high altitude. High Alt Med Biol. 2004;5:180-9. [PMID:
sickness, high-altitude pulmonary edema, and high-alti- 15265339]
tude cerebral edema. Acute mountain sickness is usually 18. Lahiri S, Maret K, Sherpa MG. Dependence of high altitude sleep apnea on
self-limiting and often resolves after 2 or 3 days. High- ventilatory sensitivity to hypoxia. Respir Physiol. 1983;52:281-301. [PMID:
6412339]
altitude pulmonary edema is much more serious, and re-
19. Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JA. Effect of
cent work indicates that the mechanism involves damage ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J
to pulmonary capillaries caused by uneven hypoxic pulmo- Respir Crit Care Med. 2002;165:1251-60. [PMID: 11991874]
nary vasoconstriction. High-altitude cerebral edema is also 20. West JB, Hackett PH, Maret KH, Milledge JS, Peters RM Jr, Pizzo CJ, et
potentially fatal, but the mechanism is poorly understood. al. Pulmonary gas exchange on the summit of Mount Everest. J Appl Physiol.
All 3 conditions respond well to immediate descent. 1983;55:678-87. [PMID: 6415007]
21. Pugh LG. Blood volume and haemoglobin concentration at altitudes above
18,000 ft (5500 m). J Physiol (Lond). 1964;170:344-53.
From University of California, San Diego, La Jolla, California. 22. Singh MV, Rawal SB, Tyagi AK. Body fluid status on induction, reinduc-
tion and prolonged stay at high altitude of human volunteers. Int J Biometeorol.
1990;34:93-7. [PMID: 2228301]
Grant Support: By National Institutes of Health grant RO1 HL 60698.
23. Pugh LGCE. Animals in high altitude: man above 5000 meters—mountain
exploration. In: Dill DB, ed. Handbook of Physiology. Adaptation to Environ-
Potential Financial Conflicts of Interest: None disclosed. ment. Washington, DC: American Physiological Society; 1984:861-8.
798 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 www.annals.org
www.annals.org 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 799
altitude cerebral edema evaluated with magnetic resonance imaging: clinical cor- Bolivian Aymara. Am J Phys Anthropol. 1998;106:385-400. [PMID: 9696153]
relation and pathophysiology. JAMA. 1998;280:1920-5. [PMID: 9851477] 77. Sui GJ, Liu YH, Cheng XS, Anand IS, Harris E, Harris P, et al. Subacute
73. Ferrazzini G, Maggiorini M, Kriemler S, Bärtsch P, Oelz O. Successful infantile mountain sickness. J Pathol. 1988;155:161-70. [PMID: 2969047]
treatment of acute mountain sickness with dexamethasone. Br Med J (Clin Res 78. Anand IS, Malhotra RM, Chandrashekhar Y, Bali HK, Chauhan SS, Jindal
Ed). 1987;294:1380-2. [PMID: 3109663] SK, et al. Adult subacute mountain sickness—a syndrome of congestive heart
74. Hurtado A. Chronic mountain sickness. JAMA. 1942;120:1278-82. failure in man at very high altitude. Lancet. 1990;335:561-5. [PMID: 1968575]
75. Kryger M, McCullough R, Doekel R, Collins D, Weil JV, Grover RF. 79. Hecht HH, Kuida H, Lange RL, Horne JL, Brown AM. Brisket disease. III.
Excessive polycythemia of high altitude: role of ventilatory drive and lung disease. Clinical features and hemodynamic observations in altitude-dependent right heart
Am Rev Respir Dis. 1978;118:659-66. [PMID: 707889] failure of cattle. Am J Med. 1962;32:171-83. [PMID: 13905831]
76. Beall CM, Brittenham GM, Strohl KP, Blangero J, Williams-Blangero S, 80. Clarke C, Duff J. Mountain sickness, retinal haemorrhages, and acclimatisa-
Goldstein MC, et al. Hemoglobin concentration of high-altitude Tibetans and tion on Mount Everest in 1975. Br Med J. 1976;2:495-7. [PMID: 953646]
800 16 November 2004 Annals of Internal Medicine Volume 141 • Number 10 www.annals.org